Subscribe To

Price Alert Latest News Economic Calendar News

CERS / Cerus Corporation's (CERS) CEO Obi Greenman on Q2 2022 Results - Earnings Call Transcript

Cerus Corporation (NASDAQ:CERS ) Q2 2022 Earnings Conference Call August 4, 2022 4:30 PM ET Company Participants Matt Notarianni - Senior Director-Investor Relations Obi Greenman - President and Chief Executive Officer Vivek Jayaraman - Chief Operating Officer Kevin Green - Chief Financial Officer Richard Benjamin - Chief Medical Officer Conference Call Participants Mathew Blackman - Stifel Brandon Folkes - Cantor Fitzgerald Josh Jennings - Cowen Operator Good day, ladies and gentlemen. Thank you for standing by and welcome to the Cerus Corporation Second Quarter 2022 Earnings Conference Call. Read More

Demo Live Account See Partner Details

Content Topics

Cerus

Corporation

CERS

Greenman

2022

Results

Earnings

Corporation s

cers

Transcript

Stock

Posted: Aug 4 2022, 18:31

Author Name: Seeking Alpha

CERS News

By Seeking Alpha
November 2, 2023

Cerus Corporation (CERS) Q3 2023 Earnings Call Transcript

Cerus Corporation (NASDAQ:CERS ) Q3 2023 Earnings Conference Call November 2, 2023 4:30 PM ET Company Participants Jessica Hanover - Vice President of

By Zacks Investment Research
November 2, 2023

Cerus (CERS) Reports Q3 Loss, Lags Revenue Estimates

Cerus (CERS) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of $0.05. This compares to loss of $0.05

By Zacks Investment Research
August 2, 2023

Cerus (CERS) Reports Q2 Loss, Lags Revenue Estimates

Cerus (CERS) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of a loss of $0.05. This compares to loss of $0.05

By 24/7 Wall Street
July 15, 2023

5 Stocks Under $10 With Massive Upside Potential and ARK's Cathie Wood Loves Two of Them

While Most of Wall Street focuses on large and mega-cap stocks, as they provide a degree of safety and liquidity, many investors are limited in the am

By Seeking Alpha
May 10, 2023

Cerus Corporation: Cash Burn Remains Concerning

Today, we put medical device concern Cerus Corporation in the spotlight. Cerus has some current challenges, which management believes are temporary.

By Zacks Investment Research
May 4, 2023

Cerus (CERS) Reports Q1 Loss, Lags Revenue Estimates

Cerus (CERS) came out with a quarterly loss of $0.09 per share versus the Zacks Consensus Estimate of a loss of $0.05. This compares to loss of $0.07

By Business Wire
April 20, 2023

Cerus Corporation to Release First Quarter 2023 Financial Results on May 4, 2023

CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (Nasdaq: CERS) announced today that its first quarter 2023 financial results will be released on T

By Seeking Alpha
February 28, 2023

Cerus Corp (CERS) Q4 2022 Earnings Call Transcript

Cerus Corp (NASDAQ:CERS ) Q4 2022 Earnings Conference Call February 28, 2023 4:30 PM ET Company Participants Joel Trujillo - Senior Director, IR Willi

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.